Press release
Microbiome Drugs Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports
Microbiome Drugs Market SizeThe global Microbiome Drugs market is projected to grow from US$ 305.3 million in 2023 to US$ 1815.7 million by 2029, at a Compound Annual Growth Rate (CAGR) of 34.6% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-1H9391/Global_Microbiome_Drugs_Market_Insights_and_Forecast_to_2028
Microbiome Drugs Market
Microbiome Drug is a kind of medicine made with microorganisms. According to the source, it is divided into three categories: drugs derived from whole or part of microorganisms, drugs derived from microbial primary metabolites, and drugs derived from microbial secondary metabolites.
Market Analysis and Insights: Global Microbiome Drugs Market
North America and Europe hold most of market share of microbiome drugs, and North America occupies a share over 77%, on the other hand, Europe takes a share of over 22% in total. Global core microbiome drugs manufacturers include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics etc.
Report Includes
This report presents an overview of global market for Microbiome Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Microbiome Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Microbiome Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microbiome Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Microbiome Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by symptom, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Microbiome Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma and Second Genome, etc.
Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-1H9391/Global_Microbiome_Drugs_Market_Insights_and_Forecast_to_2028
Segment by Type
• Oral Dosage Form
• Enteric Capsules
Segment by Symptom
• Gastrointestinal Disorders
• Autoimmune Disorders
• Diabetes
• Cancer
• Others
By Company
Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma, Second Genome, AOBiome, Rebiotix, Metabiomics, Ritter Pharmaceuticals, Symberix, OpenBiome, Azitra, Osel
View full report
https://reports.valuates.com/market-reports/QYRE-Auto-1H9391/global-microbiome-drugs
Get similar reports
1. https://reports.valuates.com/market-reports/QYRE-Auto-28Z10629/global-skin-microbiome-modulator-sales
2. https://reports.valuates.com/market-reports/QYRE-Auto-38M9495/global-human-microbiome-therapeutic-drugs
3. https://reports.valuates.com/market-reports/QYRE-Auto-15L2313/global-microbiome-sequencing-services
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Microbiome Drugs Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports here
News-ID: 3280138 • Views: …
More Releases from Valuates Reports
Ion Nitriding Equipment Market Share Accelerates with Advanced Surface Hardening …
Ion Nitriding Equipment Market Size
The global market for Ion Nitriding Equipment was valued at US$ 163 million in the year 2024 and is projected to reach a revised size of US$ 216 million by 2031, growing at a CAGR of 4.1% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-35S17150/Global_Ion_Nitriding_Equipment_Market_Research_Report_2024
The Ion Nitriding Equipment Market is witnessing steady market growth driven by rising demand for advanced surface hardening technologies that enhance wear resistance, fatigue…
Absorbable Hemostat Powder Market Share Driven by Rising Surgical Procedures and …
Absorbable Hemostat Powder - Market Size
The global market for Absorbable Hemostat Powder was estimated to be worth US$ 5538 million in 2023 and is forecast to a readjusted size of US$ 8279.9 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-24D7689/Global_Absorbable_Hemostat_Powder_Market_Insights_and_Forecast_to_2028
The Absorbable Hemostat Powder Market is experiencing consistent market growth fueled by increasing surgical volumes, expanding trauma care services, and growing demand for rapid…
Auxiliary Inverter Market Share Driven by Renewable Integration and Distributed …
Auxiliary Inverter Market
The global market for Auxiliary Inverter was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-22L12510/Global_Auxiliary_Inverter_Market_Research_Report_2022
The Auxiliary Inverter Market is experiencing sustained market growth as renewable energy adoption and distributed power systems continue to expand across residential, commercial, and utility-scale applications. Auxiliary inverters play a…
External Hemostatic Device Market Share Driven by Surgical Volume Growth and Eme …
External Hemostatic Device Market Size
The global market for External Hemostatic Device was valued at US$ 236 million in the year 2024 and is projected to reach a revised size of US$ 401 million by 2031, growing at a CAGR of 8.0% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-8U8740/Global_External_Hemostatic_Device_Market_Insights_and_Forecast_to_2028
The External Hemostatic Device Market is experiencing steady market growth driven by rising surgical procedures, increasing trauma cases, and growing emphasis on rapid bleeding…
More Releases for Microbiome
Microbiome Sequencing Service Market Expanding Rapidly with Advances in Microbio …
Market Overview
The microbiome sequencing service market is estimated to be valued at USD 2.19 Bn in 2025 and is expected to reach USD 4.64 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.
Coherent Market Insights has released a comprehensive new report offering an in-depth analysis of the Microbiome Sequencing Service Market from 2025 to 2032. This study provides reliable global and regional projections,…
Global Microbiome Market | Global Microbiome Industry | Global Microbiome Market …
The microbiome market comprises of sales of bioactive molecules and linked products which are utilized as immunotherapeutic agents in pharmaceuticals industry. The microbiome market is principally engaged in the improvement and sales of such bioactive products which are utilized as immunotherapy for a wide variability of conditions such as infectious syndromes, endocrine & metabolic disorders, inflammatory conditions, cancer, irritable bowel syndrome, neurological syndromes, hematological disorders and cardiovascular sickness as well.
According…
Global Microbiome Sequencing Services Market to 2022| Metabiomics, Microbiome Th …
Albany, NY, 29th January : Recent research and the current scenario as well as future market potential of "Microbiome Sequencing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022" globally.
Global Microbiome Sequencing Services Market: Overview
The global microbiome sequencing services market is profiled in detail in the report with the help of detailed historical databases, which illustrate the historical growth patterns of the microbiome sequencing…
Improved microbiome sequencing capabilities are likely to boost the global micro …
According to the latest market report published by Persistence Market Research, titled ‘Microbiome Therapeutics Market Potential: Global Pipeline Analysis and Assessment 2018 – 2025’, the global microbiome therapeutics market is expected to exhibit an exponential CAGR of 62.9% during the forecast period 2018–2025.
Request for sample report: https://www.persistencemarketresearch.com/samples/7990
Persistence Market Research estimates that the global market for microbiome therapeutics is expected to be valued at US$ 10.1 Mn in 2018 and is…
Global Microbiome Sequencing Services Market to 2022| Metabiomics, Microbiome Th …
Albany, NY, 1st November : Recent research and the current scenario as well as future market potential of "Microbiome Sequencing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022" globally.
Global Microbiome Sequencing Services Market: Overview
The global microbiome sequencing services market is profiled in detail in the report with the help of detailed historical databases, which illustrate the historical growth patterns of the microbiome sequencing…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
